EP3811977A1 — Method for synthesis of reactive conjugate clusters
Assigned to Ionis Pharmaceuticals Inc · Expires 2021-04-28 · 5y expired
What this patent protects
Provided herein are improved methods for the synthesis of reactive conjugate clusters and intermediates used in such methods. In particular, improvements are provided that enhance the synthesis of reactive conjugate clusters by reducing the number of synthetic steps required. The…
USPTO Abstract
Provided herein are improved methods for the synthesis of reactive conjugate clusters and intermediates used in such methods. In particular, improvements are provided that enhance the synthesis of reactive conjugate clusters by reducing the number of synthetic steps required. The reactive conjugate clusters prepared using the improved methods don't include any transacylation impurities that are formed using existing methods. The improved methods also provide an increase in overall yield and a cost benefit over existing methods.The reactive conjugate cluster has the formula:(L-A-N(H)C(=O)-E-)<sub>m</sub>-B<sub>ga</sub>wherein:L is a ligand;A is C2 to C10 alkyl optionally interrupted with one or more groups selected from -O-, -N(H)- and C(=O);E is a single bond or C1 to C10 alkyl optionally interrupted with one or more groupsselected from -O-, -N(H)-and C(=O);B<sub>ga</sub> is a reactive branching group;m is from 2 to 6- and C(=O); m is from 2 to about 6;
Drugs covered by this patent
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.